Team:Trieste/data

From 2012.igem.org

(Difference between revisions)
(fix links)
 
(54 intermediate revisions not shown)
Line 3: Line 3:
<div id="body">
<div id="body">
-
    <div id="container"> <!-- start container -->  
+
<div id="container"> <!-- start container -->  
-
        </html>{{Team:Trieste/menu}}<html>
+
</html>{{Team:Trieste/menu}}<html>
<div id="content"> <!-- start content -->
<div id="content"> <!-- start content -->
-
        <h1 id="h1_lf" class="main_tit"><div>Data</div></h1>
+
<h1 id="h1_lf" class="main_tit"><div>Data</div></h1>
-
            <h1 id="h1_rt" class="main_tit"><div>More</div></h1>
+
<h1 id="h1_rt" class="main_tit"><div>More</div></h1>
-
            <div id="box_main"> <!-- start box_main -->
+
<div id="box_main"> <!-- start box_main -->
-
                <div class="box_contenuti">
+
<div class="box_contenuti">
-
<center><img src="https://static.igem.org/mediawiki/2012/a/a8/Progetto_copia.jpg" width="700px"/></center>
+
<h1>An overview of our system</h1>
-
<br/>
+
<center><img src="https://static.igem.org/mediawiki/2012/a/a8/Progetto_copia.jpg" width="700px"/></center>
-
<br/>
+
<p>
-
<strong> Our favourite parts:</strong>
+
<strong>This is a diagram summarising our system. It consists of two parts: the production of Ab against NoroVirus and the gene guard.</strong><br/>
-
<br/>
+
Concerning the gene guard, CymR inhibits the T5 Cumate Operator Promoter avoiding the production of the T4 Holin (permeabilizes the cytoplasmatic membrane) and the LL 37 cathelicidin (human antimicrobial peptide able to disrupt the outer membrane).<br/>
-
<br/>
+
When the cumate is given, it binds and inactivates the CymR, derepressing the T5 Cumate Operator Promoter and allowing the expression of T4 Holin, that permeabilizes the cytoplasmatic membrane, allowing the secretion of LL 37 that disrupt the outer membrane.<br/>
-
-BBa_K875001, T5 cumate operator:  
+
Moreover, the horizontal transfer from our Nissle into another bacteria is avoided thanks to our gene guard. The receiving bacteria do not produce the CymR repressor, so the T5 Cumate Operator Promoter is activated allowing T4 Holin and LL 37 expression. Bacteria die!
-
<br/>
+
</p>
-
we have dimontrated that it is a very strong and strictly regulated promoter.Thanks to its rapid reactivity it's one of the first candidate for the expression and production of toxin in case of necessity.
+
<h2> Our favourite parts:</h2>
-
<br/>
+
<table>
-
-BBa_K875003, CymR: stringenza
+
<tbody>
-
<br/>
+
<tr>
-
we have succesfully expressed the CymR. We have also show his stringency as repressor of the T5 cumate operator that makes the all system a very useful mechanism for an high specificity expression.  
+
<td><img src="http://mmcpoker.net/images/cuori.gif" width="50px"/></td>  
-
<br/>
+
<td>
-
-BBa_K875004, LPP-OmpA-scFv:  
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/1">BBa_K875001</a>, T5 cumate operator:</h3>  
-
<br/>
+
We demonstrated that this promoter is very strong and strictly regulated. Thanks to its rapid responsiveness it's one of the first candidates for the toxin expression and production in case of necessity.
-
we have verified the production of this protein at high yield. OmpA is a very powerful method for displaying proteins on the external membrane, in this case the antibody scFv 54.6.
+
</td>
-
<br/>
+
</tr>
-
<br/>
+
<tr>
-
<strong/>The part we have improved:</strong>
+
<td><img src="http://mmcpoker.net/images/cuori.gif" width="50px"/></td>
-
<br/>
+
<td>
-
<br/>
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/3">BBa_K875003</a>, CymR:</h3>
-
-BBa_K875020, Glucosidase (Osaka 2010):
+
We expressed succesfully the CymR. We also showed his stringency as repressor of the T5 Cumate Operator. Together, CymR and T5 Cumate Operator, create a safe and tightly regulated gene guard system, which keeps under control the bacterial growth.
-
<br/>
+
</td>
-
 
+
</tr>
-
+
<tr>
-
 
+
<td><img src="http://mmcpoker.net/images/cuori.gif" width="50px"/></td>
-
 
+
<td>
-
 
+
<h3><a href="ttp://2012.igem.org/Team:Trieste/parts/4">BBa_K875004</a>, LPP-OmpA-scFv:</h3>  
-
                </div>
+
We verified the production of this protein at high yield. LPP-OmpA system is a very powerful method for protein display on the outer membrane, in this case the antibody scFv 54.6.
-
            </div> <!-- end box_main -->
+
</td>
-
            <div id="box_right"> <!-- start box_right -->
+
</tr>
-
            <ul id="sub_menu">
+
</tbody>
-
                <li><a href="https://2012.igem.org/Team:Trieste/project/mainres">Main Results</a></li>
+
</table>
-
                    <li class="select"><a href="#">Sotto menu 2</a></li>
+
<h2>The part we improved:</h2>
-
                    <li><a href="#">Sotto menu 3</a></li>
+
<table>
-
                    <li><a href="#">Sotto menu 4</a></li>
+
<tbody>
-
                    <li><a href="#">Sotto menu 5</a></li>
+
<tr>
-
                </ul>
+
<td><img src="http://www.superscommesse.it/images/stella_piena.jpg" width="50px"/></a></td>  
-
                <img src="https://static.igem.org/mediawiki/2012/b/b0/Team_trieste.jpg" alt="Team iGEM 2012" id="igem_team" />
+
<td>
-
                <div class="box_contacts">
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/10">BBa_K875020</a>, Beta-Glucosidase (Osaka 2010):</h3>
-
<h2>Contact us</h2>
+
This composite part is developed by previous work by UNITS iGEM team 2011 and Edinburgh team 2011. We improved and characterized this part demonstrating its efficiency.
-
<p>For other information, write to:</p>
+
</td>
-
                    <a href="mailto:igem2012@gmail.com" class="btn">igem2012@gmail.com</a>
+
</tr>
-
                    <div class="social">
+
</tbody>
-
                    Follow us also:
+
</table>
-
<a href="https://www.facebook.com/IGEMUNITS?ref=ts" target="_blank"><img src="https://static.igem.org/mediawiki/2012/f/f4/Ico_fb.png" alt="Facebook" class="fb" /></a>
+
<h2>Other parts that we developed:</h2>
-
                        <a href="https://twitter.com/igemunits" target="_blank"><img src="https://static.igem.org/mediawiki/2012/2/21/Ico_twitter.png" alt="twitter" class="tw" /></a>
+
<p>
-
                    </div>
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/2">BBa_K875002</a>, T5 Lac Operator:</h3>
-
                </div>
+
We showed that this promoter comes very handy for protein expression tests.
-
            </div> <!-- end box_right -->
+
</p>
-
            </html>{{Team:Trieste/footer}}<html>
+
-
        <!-- end content is included in template -->
+
<p>
-
    </div> <!-- end container -->
+
<h3><a href="https://2012.igem.org/Team:Trieste/parts/5">BBa_K875005</a>, LPP-OmpA-SIP:</h3>
 +
We designed this biobrick containing SIP as a valid alternative to scFv, because SIP confers bivalent binding properties to the antibody.
 +
</p>
 +
<p>
 +
<h3><a href="https://2012.igem.org/Team:Trieste/parts/6">BBa_K875006</a>, PelB-scFv:</h3>
 +
We created this composit biobrick to use as a system which allows secretion of proteins, in this case the antibody, first into periplasm and then extracellularly.
 +
</p>
 +
<p>
 +
<h3><a href="https://2012.igem.org/Team:Trieste/parts/7">BBa_K875007</a>, PelB-SIP:</h3>
 +
We built this biobrick (secreted version of SIP) because soluble form of SIP plays an important role in enteric infections.
 +
</p>
 +
<p>
 +
<h3><a href="https://2012.igem.org/Team:Trieste/parts/8">BBa_K875008</a>, Tse2 toxin:</h3>
 +
We demonstrated that this composit is an important suicide mechanism able to arrest the growth of prokaryotic cells.
 +
</p>
 +
<p>
 +
<h3><a href="https://2012.igem.org/Team:Trieste/parts/9">BBa_K875009</a>, LL 37:</h3>
 +
The LL 37 is a very powerful human antimicrobial peptide that kills bacteria.
 +
We are developing a new construct combining the toxin with the T4 holin which breaks the inner membrane allowing the  LL 37 to reach his target.
 +
</p>
 +
</div>
 +
</div> <!-- end box_main -->
 +
<div id="box_right"> <!-- start box_right -->
 +
<ul id="sub_menu">
 +
<li class="select"><a href="https://2012.igem.org/Team:Trieste/data">Data</a></li>
 +
</ul>
 +
<img src="https://static.igem.org/mediawiki/2012/b/b0/Team_trieste.jpg" alt="Team iGEM 2012" id="igem_team" />
 +
<div class="box_contacts">
 +
<h2>Contact us</h2>
 +
<p>For other information, write to:</p>
 +
<a href="mailto:igem2012@gmail.com" class="btn">igem2012@gmail.com</a>
 +
<div class="social">
 +
Follow us also:
 +
<a href="https://www.facebook.com/IGEMUNITS?ref=ts" target="_blank"><img src="https://static.igem.org/mediawiki/2012/f/f4/Ico_fb.png" alt="Facebook" class="fb" /></a>
 +
<a href="https://twitter.com/iGEMTrieste" target="_blank"><img src="https://static.igem.org/mediawiki/2012/2/21/Ico_twitter.png" alt="twitter" class="tw" /></a>
 +
</div>
 +
</div>
 +
</div> <!-- end box_right -->
 +
</html>{{Team:Trieste/footer}}<html>
 +
<!-- end content is included in template -->
 +
</div> <!-- end container -->
</div>
</div>
</html>
</html>

Latest revision as of 12:23, 15 October 2012

Data

More

An overview of our system

This is a diagram summarising our system. It consists of two parts: the production of Ab against NoroVirus and the gene guard.
Concerning the gene guard, CymR inhibits the T5 Cumate Operator Promoter avoiding the production of the T4 Holin (permeabilizes the cytoplasmatic membrane) and the LL 37 cathelicidin (human antimicrobial peptide able to disrupt the outer membrane).
When the cumate is given, it binds and inactivates the CymR, derepressing the T5 Cumate Operator Promoter and allowing the expression of T4 Holin, that permeabilizes the cytoplasmatic membrane, allowing the secretion of LL 37 that disrupt the outer membrane.
Moreover, the horizontal transfer from our Nissle into another bacteria is avoided thanks to our gene guard. The receiving bacteria do not produce the CymR repressor, so the T5 Cumate Operator Promoter is activated allowing T4 Holin and LL 37 expression. Bacteria die!

Our favourite parts:

BBa_K875001, T5 cumate operator:

We demonstrated that this promoter is very strong and strictly regulated. Thanks to its rapid responsiveness it's one of the first candidates for the toxin expression and production in case of necessity.

BBa_K875003, CymR:

We expressed succesfully the CymR. We also showed his stringency as repressor of the T5 Cumate Operator. Together, CymR and T5 Cumate Operator, create a safe and tightly regulated gene guard system, which keeps under control the bacterial growth.

BBa_K875004, LPP-OmpA-scFv:

We verified the production of this protein at high yield. LPP-OmpA system is a very powerful method for protein display on the outer membrane, in this case the antibody scFv 54.6.

The part we improved:

BBa_K875020, Beta-Glucosidase (Osaka 2010):

This composite part is developed by previous work by UNITS iGEM team 2011 and Edinburgh team 2011. We improved and characterized this part demonstrating its efficiency.

Other parts that we developed:

BBa_K875002, T5 Lac Operator:

We showed that this promoter comes very handy for protein expression tests.

BBa_K875005, LPP-OmpA-SIP:

We designed this biobrick containing SIP as a valid alternative to scFv, because SIP confers bivalent binding properties to the antibody.

BBa_K875006, PelB-scFv:

We created this composit biobrick to use as a system which allows secretion of proteins, in this case the antibody, first into periplasm and then extracellularly.

BBa_K875007, PelB-SIP:

We built this biobrick (secreted version of SIP) because soluble form of SIP plays an important role in enteric infections.

BBa_K875008, Tse2 toxin:

We demonstrated that this composit is an important suicide mechanism able to arrest the growth of prokaryotic cells.

BBa_K875009, LL 37:

The LL 37 is a very powerful human antimicrobial peptide that kills bacteria. We are developing a new construct combining the toxin with the T4 holin which breaks the inner membrane allowing the LL 37 to reach his target.

Team iGEM 2012

Contact us

For other information, write to:

igem2012@gmail.com
Università degli studi di Trieste ICGEB Illy Fondazione Cassa di Risparmio
iGEM 2012 iGEM 2012 iGEM 2012 iGEM 2012 iGEM 2012 iGEM 2012
HTML Hit Counter

Retrieved from "http://2012.igem.org/Team:Trieste/data"